.beta.-Superfamily conotoxins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7115708
SERIAL NO

11198847

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to .beta.-superfamily conotoxin peptides, derivatives or pharmaceutically acceptable salts thereof. The present invention is further directed to the use of this peptide, derivatives thereof and pharmaceutically acceptable salts thereof for the treatment of disorders associated with voltage-gated ion channels, ligand gated channels and other receptors. The invention is further directed to nucleic acid sequences encoding the .beta.-superfamily conotoxin peptides and encoding .beta.-superfamily conotoxin propeptides, as well as the .beta.-superfamily conotoxin propeptides.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF UTAH RESEARCH FOUNDATIONSALT LAKE CITY UT

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Garrett, James E Salt Lake City, UT 31 514
Jones, Robert M Salt Lake City, UT 167 2521
Olivera, Baldomero M Salt Lake City, UT 102 561
Watkins, Maren Salt Lake City, UT 44 122

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation